Activity value 66india Supplier,Last transaction date:
2025-04-22
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for r j pharma from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 10 transactions, with a transaction quantity of 282160 and a transaction weight of 1050.
YearTransactionsQuantityWeight
202414712877030
2025102821601050
Bill of lading data
<
1/15
>
Trade date
2025/04/22
B/L No.
c36195
Suppliers
r j pharma
Buyers
ife ins pharmaceutical ltd.
POLs
——
PODs
tin can island
Supply area
India
Purchas area
Nigeria
Weight
1050kg
Amount
30167190
Hs code
3004200000
Product tags
tibi
Product description
Containing other antibiotics
Expand
Trade date
2025/03/05
B/L No.
9848361
Suppliers
r j pharma
Buyers
ife ins pharmaceutical ltd.
r j pharma is india Supplier,
and primarily engages in the import and export business of products such as brand name,md,xtr.
According to the 52wmb.com global trade database, as of 2025-04-22, the company has completed 1730 international trades,
with its main trading regions covering vietnam,cambodia,niger etc.
The core products include HS30049099,HS30042019,HS96081099 etc,
often transported via mundra,port ahemdabad air acc inamd4, port nhava sheva sea innsa1 etc,
and its main trading partners are mega excellent trading co.ltd.,cwt trading imp exp services,domaks investment ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on r j pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.